Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

DEPARTMENTS: Pharmacology Consult

The Antidote Is Finally Here! Idarucizumab, A Specific Reversal Agent for the Anticoagulant Effects of Dabigatran

O’Malley, Patricia Anne PhD, RN, CNS

Author Information
doi: 10.1097/NUR.0000000000000192
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved